References
1. World Health Organization (WHO). WHO recommendations: induction of
labour at or beyond term. Geneva: WHO; Licence: CC BY-NC-SA 3.0 IGO;
2018.
2. Australian Institute of Health and Welfare (AIHW). Australia’s
mothers and babies 2018—in brief. Canberra:: AIHW; 2020.
3. Vogel JP, Osoti AO, Kelly AJ, Livio S, Norman JE, Alfirevic Z.
Pharmacological and mechanical interventions for labour induction in
outpatient settings. Cochrane Database Syst Rev. 2017;9:CD007701.
4. Tulek F, Gemici A, Soylemez F. Double balloon catheters: A promising
tool for induction of labor in multiparous women with unfavorable
cervices. J Turk Ger Gynecol Assoc. 2019;20(4):231-5.
5. Kehl S, Weiss C, Wamsler M, Beyer J, Dammer U, Heimrich J, et al.
Double-balloon catheter and sequential vaginal prostaglandin E2 versus
vaginal prostaglandin E2 alone for induction of labor after previous
cesarean section. Arch Gynecol Obstet. 2016;293(4):757-65.
6. Vaknin Z, Kurzweil Y, Sherman D. Foley catheter balloon vs locally
applied prostaglandins for cervical ripening and labor induction: a
systematic review and metaanalysis. Am J Obstet Gynecol.
2010;203(5):418-29.
7. Eser A, Ozkaya E, Abide CY, Eser T, Eser GY, Abike F, et al.
Transcervical Foley balloon catheter and vaginal prostaglandin E2 insert
combination vs. vaginal prostaglandin E2 insert only for induction of
labor at term: a randomized clinical trial. Arch Gynecol Obstet.
2019;299(2):451-7.
8. Henry A, Madan A, Reid R, Tracy SK, Austin K, Welsh A, et al.
Outpatient Foley catheter versus inpatient prostaglandin E2 gel for
induction of labour: a randomised trial. BMC Pregnancy Childbirth.
2013;13:25.
9. Queensland Clinical Guidelines: Translating evidence into best
clinical practice. Maternity and Neonatal Clinical Guideline: induction
of labour. Brisbane: Queensland Health March 2017.
10. Dupont C, Blanc-Petitjean P, Cortet M, Gaucher L, Salome M, Carbonne
B, et al. Dissatisfaction of women with induction of labour according to
parity: Results of a population-based cohort study. Midwifery.
2020;84:102663.
11. Lou S, Hvidman L, Uldbjerg N, Neumann L, Jensen TF, Haben JG, et al.
Women’s experiences of postterm induction of labor: A systematic review
of qualitative studies. Birth. 2019;46(3):400-10.
12. Coates R, Cupples G, Scamell A, McCourt C. Women’s experiences of
induction of labour: Qualitative systematic review and thematic
synthesis. Midwifery. 2019;69:17-28.
13. Lim SE, Tan TL, Ng GYH, Tagore S, Kyaw EEP, Yeo GSH. Patient
satisfaction with the cervical ripening balloon as a method for
induction of labour: a randomised controlled trial. Singapore Med J.
2018;59(8):419-24.
14. Ten Eikelder ML, van de Meent MM, Mast K, Rengerink KO, Jozwiak M,
de Graaf IM, et al. Women’s Experiences with and Preference for
Induction of Labor with Oral Misoprostol or Foley Catheter at Term. Am J
Perinatol. 2017;34(2):138-46.
15. Beckmann M, Acreman M, Schmidt E, Merollini KMD, Miller Y. Women’s
experience of induction of labor using PGE2 as an inpatient versus
balloon catheter as an outpatient. Eur J Obstet Gynecol Reprod Biol.
2020;249:1-6.
16. Beckmann M, Gibbons K, Flenady V, Kumar S. Induction of labour using
prostaglandin E2 as an inpatient versus balloon catheter as an
outpatient: a multicentre randomised controlled trial. BJOG.
2020;127(5):571-9.
17. Rabin R, de Charro F. EQ-5D: a measure of health status from the
EuroQol Group. Ann Med. 2001;33(5):337-43.
18. Viney R, Norman R, King MT, Cronin P, Street DJ, Knox S, et al. Time
trade-off derived EQ-5D weights for Australia. Value Health.
2011;14(6):928-36.
19. Weinstein MC, Stason WB. Foundations of cost-effectiveness analysis
for health and medical practices. N Engl J Med. 1977;296(13):716-21.
20. TreeAge Software. 2020, R1.1. Williamstown, MA: Software available
at http://www.treeage.com.
21. Lowe A, Dyson S. New Therapies for Advanced Cancers: Can Our Society
Afford Them? Is it Ethical to Deny Patients Access to Them? Actuaries
Institute 2013 Actuaries Summit; Sydney, Australia: Institute of
Actuaries of Australia; 2013.
22. Callander EJ, Creedy DK, Gamble J, Fox H, Toohill J, Sneddon A, et
al. Reducing caesarean delivery: An economic evaluation of routine
induction of labour at 39 weeks in low-risk nulliparous women. Paediatr
Perinat Epidemiol. 2020;34(1):3-11.
23. Hersh AR, Skeith AE, Sargent JA, Caughey AB. Induction of labor at
39 weeks of gestation versus expectant management for low-risk
nulliparous women: a cost-effectiveness analysis. Am J Obstet Gynecol.
2019;220(6):590 e1- e10.
24. Walker KF, Dritsaki M, Bugg G, Macpherson M, McCormick C, Grace N,
et al. Labour induction near term for women aged 35 or over: an economic
evaluation. BJOG. 2017;124(6):929-34.
25. Kaimal AJ, Little SE, Odibo AO, Stamilio DM, Grobman WA, Long EF, et
al. Cost-effectiveness of elective induction of labor at 41 weeks in
nulliparous women. Am J Obstet Gynecol. 2011;204(2):137 e1-9.
26. Austin K, Chambers GM, de Abreu Lourenco R, Madan A, Susic D, Henry
A. Cost-effectiveness of term induction of labour using inpatient
prostaglandin gel versus outpatient Foley catheter. Aust N Z J Obstet
Gynaecol. 2015;55(5):440-5.
27. Ten Eikelder M, van Baaren GJ, Oude Rengerink K, Jozwiak M, de Leeuw
JW, Kleiverda G, et al. Comparing induction of labour with oral
misoprostol or Foley catheter at term: cost-effectiveness analysis of a
randomised controlled multi-centre non-inferiority trial. BJOG.
2018;125(3):375-83.
28. van Baaren GJ, Jozwiak M, Opmeer BC, Oude Rengerink K, Benthem M,
Dijksterhuis MG, et al. Cost-effectiveness of induction of labour at
term with a Foley catheter compared to vaginal prostaglandin E(2) gel
(PROBAAT trial). BJOG. 2013;120(8):987-95.
29. Alfirevic Z, Keeney E, Dowswell T, Welton NJ, Medley N, Dias S, et
al. Which method is best for the induction of labour? A systematic
review, network meta-analysis and cost-effectiveness analysis. Health
Technol Assess. 2016;20(65):1-584.